Genitourinary Cancer
Feature
NHS England starts pilot trial of blood test for many cancers
Patients with head and neck, pancreatic, and other hard-to-spot cancers could soon have their disease picked up early with a simple blood test if...
From the Journals
Cancer rates on the rise in adolescents and young adults
From the Journals
Fear of recurrence highly prevalent in RCC survivors
About 55% of survivors surveyed expressed fear of renal cell carcinoma recurrence.
News from the FDA/CDC
FDA approves first agent for PSMA-PET imaging in prostate cancer
The diagnostic agent Gallium 68 PSMA-11 has been approved for institutional use only.
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
Conference Coverage
Risk factors for severe immune-related AEs identified
A nationwide cohort study of more than 14,000 patients finds combination immune checkpoint inhibitor therapy, younger age, and a lung cancer...
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
Conference Coverage
Predictors of upstaging on PSMA PET/CT may help guide its use
Patients with high-risk prostate cancer having more positive cores on biopsy or a higher Gleason grade were most likely to experience upstaging...
From the Journals
Testicular cancer link to below-the-waist scans, x-rays?
From the Journals
New cancer drugs may have saved more than 1.2 million Americans
Cancer drugs approved between 2000 and 2016 significantly reduced deaths from the most common cancers in the United States.
From the Journals
‘Test all patients with cancer’: One in eight have inherited mutations
Nearly half of mutations identified in this study would have been missed under current guidelines.